Ayala Pharmaceuticals Inc (ADXS)

[James salmon]

I think in recent financing some may have bought in to obtain warrants, so some selling has taken place. Now this will not go on for much longer, and we should see a good rise in price. I think as we move towards end of November price will appreciate as we get closer to FDA response to Breakthrough designation.

I see news today, making it very difficult for FDA to deny this. It's all a matter of time.

Before then I see update coming on Canine Study.